These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

976 related items for PubMed ID: 15114626

  • 1. Tyrosine hydroxylase and dopamine transporter expression following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of the mouse nigrostriatal pathway.
    Jakowec MW, Nixon K, Hogg E, McNeill T, Petzinger GM.
    J Neurosci Res; 2004 May 15; 76(4):539-50. PubMed ID: 15114626
    [Abstract] [Full Text] [Related]

  • 2. Behavioral motor recovery in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned squirrel monkey (Saimiri sciureus): changes in striatal dopamine and expression of tyrosine hydroxylase and dopamine transporter proteins.
    Petzinger GM, Fisher B, Hogg E, Abernathy A, Arevalo P, Nixon K, Jakowec MW.
    J Neurosci Res; 2006 Feb 01; 83(2):332-47. PubMed ID: 16385585
    [Abstract] [Full Text] [Related]

  • 3. Exercise-induced behavioral recovery and neuroplasticity in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse basal ganglia.
    Fisher BE, Petzinger GM, Nixon K, Hogg E, Bremmer S, Meshul CK, Jakowec MW.
    J Neurosci Res; 2004 Aug 01; 77(3):378-90. PubMed ID: 15248294
    [Abstract] [Full Text] [Related]

  • 4. Effects of blocking the dopamine biosynthesis and of neurotoxic dopamine depletion with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on voluntary wheel running in mice.
    Leng A, Mura A, Hengerer B, Feldon J, Ferger B.
    Behav Brain Res; 2004 Oct 05; 154(2):375-83. PubMed ID: 15313025
    [Abstract] [Full Text] [Related]

  • 5. Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.
    Goldberg NR, Fields V, Pflibsen L, Salvatore MF, Meshul CK.
    Neurobiol Dis; 2012 Mar 05; 45(3):1051-67. PubMed ID: 22198503
    [Abstract] [Full Text] [Related]

  • 6. Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice.
    Kurosaki R, Muramatsu Y, Kato H, Watanabe Y, Imai Y, Itoyama Y, Araki T.
    Eur Neuropsychopharmacol; 2005 Jan 05; 15(1):57-67. PubMed ID: 15572274
    [Abstract] [Full Text] [Related]

  • 7. Neural mechanisms underlying motor dysfunction as detected by the tail suspension test in MPTP-treated C57BL/6 mice.
    Mori A, Ohashi S, Nakai M, Moriizumi T, Mitsumoto Y.
    Neurosci Res; 2005 Mar 05; 51(3):265-74. PubMed ID: 15710490
    [Abstract] [Full Text] [Related]

  • 8. Selective alterations of gene expression in mice induced by MPTP.
    Xu Z, Cawthon D, McCastlain KA, Slikker W, Ali SF.
    Synapse; 2005 Jan 05; 55(1):45-51. PubMed ID: 15499605
    [Abstract] [Full Text] [Related]

  • 9. Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice.
    D'Astous M, Morissette M, Tanguay B, Callier S, Di Paolo T.
    Synapse; 2003 Jan 05; 47(1):10-4. PubMed ID: 12422368
    [Abstract] [Full Text] [Related]

  • 10. Environmental enrichment in adulthood eliminates neuronal death in experimental Parkinsonism.
    Faherty CJ, Raviie Shepherd K, Herasimtschuk A, Smeyne RJ.
    Brain Res Mol Brain Res; 2005 Mar 24; 134(1):170-9. PubMed ID: 15790541
    [Abstract] [Full Text] [Related]

  • 11. Differential effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the olfactory bulb and the striatum in mice.
    Mitsumoto Y, Mori A, Ohashi S, Nakai M, Moriizumi T.
    Neurosci Res; 2005 Jan 24; 51(1):111-5. PubMed ID: 15596247
    [Abstract] [Full Text] [Related]

  • 12. Effect of MPTP-induced denervation on basal ganglia GABA(B) receptors: correlation with dopamine concentrations and dopamine transporter.
    Calon F, Lavertu N, Lemieux AM, Morissette M, Goulet M, Grondin R, Blanchet PJ, Bédard PJ, Di Paolo T.
    Synapse; 2001 Jun 01; 40(3):225-34. PubMed ID: 11304760
    [Abstract] [Full Text] [Related]

  • 13. Spontaneous regeneration of nigrostriatal dopaminergic neurons in MPTP-treated C57BL/6 mice.
    Mitsumoto Y, Watanabe A, Mori A, Koga N.
    Biochem Biophys Res Commun; 1998 Jul 30; 248(3):660-3. PubMed ID: 9703982
    [Abstract] [Full Text] [Related]

  • 14. Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor-alpha.
    Sriram K, Miller DB, O'Callaghan JP.
    J Neurochem; 2006 Feb 30; 96(3):706-18. PubMed ID: 16405514
    [Abstract] [Full Text] [Related]

  • 15. l-dopa-induced reversal in striatal glutamate following partial depletion of nigrostriatal dopamine with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Holmer HK, Keyghobadi M, Moore C, Meshul CK.
    Neuroscience; 2005 Feb 30; 136(1):333-41. PubMed ID: 16198485
    [Abstract] [Full Text] [Related]

  • 16. Catalpol attenuates MPTP induced neuronal degeneration of nigral-striatal dopaminergic pathway in mice through elevating glial cell derived neurotrophic factor in striatum.
    Xu G, Xiong Z, Yong Y, Wang Z, Ke Z, Xia Z, Hu Y.
    Neuroscience; 2010 Apr 28; 167(1):174-84. PubMed ID: 20123001
    [Abstract] [Full Text] [Related]

  • 17. Mechanisms of MPTP toxicity and their implications for therapy of Parkinson's disease.
    Watanabe Y, Himeda T, Araki T.
    Med Sci Monit; 2005 Jan 28; 11(1):RA17-23. PubMed ID: 15614202
    [Abstract] [Full Text] [Related]

  • 18. Damage to the nigrostriatal system in the MPTP-treated SAMP8 mouse.
    Liu J, Wang YY, Liu L, Wang QD, Yuan ZY, Zhang ZX, Gu P, Wang MW.
    Neurosci Lett; 2008 Dec 26; 448(2):184-8. PubMed ID: 18977411
    [Abstract] [Full Text] [Related]

  • 19. H MRS identifies lactate rise in the striatum of MPTP-treated C57BL/6 mice.
    Koga K, Mori A, Ohashi S, Kurihara N, Kitagawa H, Ishikawa M, Mitsumoto Y, Nakai M.
    Eur J Neurosci; 2006 Feb 26; 23(4):1077-81. PubMed ID: 16519673
    [Abstract] [Full Text] [Related]

  • 20. Decreased expression of kynurenine aminotransferase-I (KAT-I) in the substantia nigra of mice after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment.
    Knyihár-Csillik E, Csillik B, Pákáski M, Krisztin-Péva B, Dobó E, Okuno E, Vécsei L.
    Neuroscience; 2004 Feb 26; 126(4):899-914. PubMed ID: 15207325
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.